Hormone Replacement Therapy
Fibrinolytic Potential Is Significantly Increased by Oestrogen Treatment in Post-Menopausal Women with Mild Dyslipidaemia
Published in Women's Health Weekly, October 19th, 1998
According to the authors' abstract of an article published in Heart, "Objective: To study the effects of oestrogen replacement treatment on fibrinolytic potential in post-menopausal women. Designs: Randomised, double-blind, placebo-controlled trial of oral 17 beta-oestradiol. Setting: Subjects were evaluated in the outpatient setting. Patients: Nineteen post-menopausal women with mild dyslipidaemia, aged 44 to 69 years (mean (SD) 55.7 (6.7)). Main Outcome Measures: Fibrinolytic activity (fibrin plate assay) and tissue plasminogen activator (t-PA) antigen were measured at baseline and after three, six, and nine weeks of each treatment. ...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Domestic Violence
Domestic Violence Is a Major Health Issue, Physician Emphasizes - Domestic Violence
Women Subjected to Any Violence Have Health Problems - Ovarian Endometriosis
Protected Left Ovary Prone to Lesions - Bulimia Nervosa (Etiology)
Study Suggests Biological Cause for Eating Disorders - Cervical Cancer (Diagnostics)
New HPV DNA Testing May Help Identify Those at High Risk - Chronic Fatigue Syndrome (Therapy)
New Data on CFS Treatment Reported - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
